TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
GHN Pharma AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
1,341
|
198
|
4,446 |
Financial expenses |
7
|
1,628
|
230 |
Earnings before taxes |
3,553
|
-1,988
|
11,177 |
EBITDA |
-40
|
-1,346
|
-1,126 |
Total assets |
64,175
|
60,555
|
68,747 |
Current assets |
1,994
|
1,606
|
2,462 |
Current liabilities |
568
|
140
|
248 |
Equity capital |
63,607
|
60,414
|
68,499 |
- share capital |
277
|
275
|
300 |
Employees (average) |
2
![]() |
2
![]() |
2 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
99.1%
|
99.8%
|
99.6% |
Turnover per employee |
670
|
99
|
2,223 |
Profit as a percentage of turnover |
265.0%
|
-1004.0%
|
251.4% |
Return on assets (ROA) |
5.5%
|
-0.6%
|
16.6% |
Current ratio |
351.1%
|
1147.1%
|
992.7% |
Return on equity (ROE) |
5.6%
|
-3.3%
|
16.3% |
Change turnover |
1,143
|
-3,888
|
4,387 |
Change turnover % |
575%
|
-95%
|
7448% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.